The technology MicroBiOil™ allows the production of biofuels and bioproducts from non-food raw materials Neol Bio, a subsidiary of Neuron Bio, has been granted with the Spanish patent “Production of microbial oils” that describes a method to produce oils from agricultural residues, such as wheat straw or sugarcane bagasse. This new technology is basedRead more →
Very long chain fatty acids are obtained by applying this new technology without using food chain resources Neol Bio, subsidiary of Neuron Bio, has filed a new patent application for a production method of very long chain fatty acids using genetically improved variants of its proprietary microorganism Neoleum®. These very long chain fatty acids (arachidonic, erucic,Read more →
Last year the company was granted with the European patent to protect its compound NST0037. The Japanese Patent Office (JPO) granted to Neuron Bio the patent “”Neuroprotective, hypocholesterolemic and antiepileptic compound”, which protects the molecule NST0037 as product and as use for the prevention and treatment of various pathologies of the Central Nervous System amongRead more →
Neol Bio, subsidiary of Neuron Bio (NEU.MAB), has received requests of qualified investors for the subscription of 100% for the capital increase that arises up to €1.55 million and was approved on 26 June by its Board of Directors, thus it will be totally subscribed within the timeframe set out. The subscription conditions suppose aRead more →
Experiments carried out by Neuron Bio in collaboration with Dr. Patricia Cogram of the University of Chile and financed by FRAXA Research Foundation, have shown promising results of the compound NST0076 to treat fragile X syndrome (FXS). The fragile X syndrome is the most frequent genetic syndrome that causes hereditary intellectual disability and one ofRead more →
Español
English